APA ציטוט

Nagai, H., Ikematsu, H., Tenjinbaru, K., Maeda, A., Dramé, M., & Roman, F. P. (2010). A phase II, open-label, multicentre study to evaluate the immunogenicity and safety of an adjuvanted prepandemic (H5N1) influenza vaccine in healthy Japanese adults. BioMed Central.

Citação norma Chicago

Nagai, Hideaki, Hideyuki Ikematsu, Kazuyoshi Tenjinbaru, Atsushi Maeda, Mamadou Dramé, and François P. Roman. A Phase II, Open-label, Multicentre Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Prepandemic (H5N1) Influenza Vaccine in Healthy Japanese Adults. BioMed Central, 2010.

ציטוט MLA

Nagai, Hideaki, et al. A Phase II, Open-label, Multicentre Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Prepandemic (H5N1) Influenza Vaccine in Healthy Japanese Adults. BioMed Central, 2010.

אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.